Solid Tumors Harboring MET Amplification
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Telisotuzumab Adizutecan | AbbVie Inc. (ABBV) |
Frequently asked questions
How many drugs are in development for Solid Tumors Harboring MET Amplification?
BioSniper tracks 1 drug in development for Solid Tumors Harboring MET Amplification across 1 company.
How many clinical trials target Solid Tumors Harboring MET Amplification?
There are 1 clinical trial targeting Solid Tumors Harboring MET Amplification tracked by BioSniper.
Deep-dive into Solid Tumors Harboring MET Amplification
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis